PI3K/Akt inhibitor partly decreases TNF-α-induced activation of fibroblast-like synoviocytes in osteoarthritis

被引:62
|
作者
Liu, Songyang [1 ]
Cao, Chenxi [1 ,2 ]
Zhang, Yujun [3 ,4 ]
Liu, Guangyu [1 ]
Ren, Weixia [3 ,4 ]
Ye, Yanqi [1 ]
Sun, Tiezheng [1 ]
机构
[1] Peking Univ, Peoples Hosp, Arthritis Clin & Res Ctr, Beijing 100044, Peoples R China
[2] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100044, Peoples R China
[3] Peking Univ, Peoples Hosp, Inst Clin Mol Biol, Beijing 100044, Peoples R China
[4] Peking Univ, Peoples Hosp, Cent Lab, Beijing 100044, Peoples R China
关键词
PI3K/Akt inhibitor; TNF-alpha; Cadherin-11; Osteoarthritis; Fibroblast-like synoviocytes; PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR; CADHERIN-11; ARTHRITIS; SYNOVITIS; PATHOLOGY; INFLAMMATION; PROGRESSION; EXPRESSION; MIGRATION; CELLS;
D O I
10.1186/s13018-019-1394-4
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: The Cadherin-11 and PI3K/Akt pathway are increasingly recognized as the potential therapeutic target of osteoarthritis (OA) synovitis. The study aimed to investigate the role of PI3K/Akt signaling pathway in the expression of Cadherin-11 and migration and invasive capacity of fibroblast-like synoviocytes (FLS) of OA patients under stimulation of TNF-alpha and to explore the effect of the PI3K/Akt inhibitor and Cadherin-11 antibody in the therapy of the collagenase-induced osteoarthritis (CIOA) mice. Methods: FLS were primarily cultured from synovium of osteoarthritic patients during total knee arthroplasty. Under the simulation of TNF-alpha, with or without PI3K/Akt inhibitor LY294002, Cadherin-11 expression was detected by real-time PCR and Western blot, as well as the migration and invasive capacity changes of OA FLS. Cadherin-11 antibody was injected intraarticularly or LY294002 was injected intraperitoneally in CIOA mice to evaluate the changes of synovitis score, cartilage damage, and Cadherin-11 expression. Results: TNF-alpha stimulation increased Cadherin-11 expression at mRNA and protein level in OA FLS and also increased the phosphorylation-dependent activation of Akt. PI3K inhibitor LY294002 attenuated TNF-alpha-induced overexpression of Cadherin-11 and decreased the invasive capacity of OA FLS. Intraperitoneal injection of PI3K inhibitor LY294002 could decrease the Cadherin-11 protein expression in synovium of CIOA mice, although it has no significant inhibitory effect on synovitis and cartilage damage. Intraarticular injection of Cadherin-11 antibody attenuated the synovitis and cartilage damage in the CIOA joints and decreased Cadherin-11 expression in the synovial lining. Conclusions: PI3K/Akt pathway was associated with TNF-alpha-induced activation of OA FLS, which may involve in the pathogenesis of osteoarthritis. Anti-Cadherin-11 therapy in CIOA mice could attenuate the pathological changes of OA joints.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis
    Yan Liu
    Yun Feng Pan
    You-qiu Xue
    Lin-kai Fang
    Xing-hua Guo
    Xin Guo
    Meng Liu
    Bi-yao Mo
    Meng-ru Yang
    Fang Liu
    Yun-ting Wu
    Nancy Olsen
    Song Guo Zheng
    Cellular & Molecular Immunology, 2018, 15 : 171 - 181
  • [22] uPAR Promotes Tumor-like Biologic Role of Fibroblast-like Synoviocytes through PI3K/Akt Signaling Pathway in Patients with Rheumatoid Arthritis
    Liu, Yan
    Pan, Yunfeng
    Zheng, Song Guo
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [23] COX-2 Inhibitor Contributes Cell Death in Rheumatoid Arthritis Fibroblast-like Synoviocytes Via PI3K/AKT/mTOR Signaling Pathway Triggered By Autophagy
    Kim, Sang-Hyon
    Bang, Jihye
    Kim, Ji-Min
    Son, Chang-Nam
    Chae, Jin-Nyeong
    Jeong, Hye-Jin
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [24] Silencing CoREST inhibits the viability and migration of fibroblast-like synoviocytes in TNF-α-induced rheumatoid arthritis
    Yu, Ziliang
    Chen, Feihu
    Liu, Hao
    Fan, Jianbo
    Ding, Xiaomin
    Zhu, Xinhui
    Cui, Shengyu
    Yi, Hong
    Zhou, Xiaogang
    Hu, Yalong
    Liu, Wei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 23 (02)
  • [25] Artesunate Inhabits Migration and Invasion of Fibroblast-like Synoviocytes and Matrix Metalloproteinases Expression Via Suppression of PI3K/Akt Pathway in Rheumatoid Arthritis
    Ma, Jian-Da
    Jing, Jun
    Yan, Tao
    Mo, Ying-Qian
    Dai, Lie
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [26] Gastrin-releasing peptide and its receptor increase arthritis fibroblast-like synoviocytes invasiveness through activating the PI3K/AKT pathway
    Clarimundo, Vanessa Schuck
    Farinon, Mirian
    Pedo, Renata Ternus
    Nunes Teixeira, Vivian Oliveira
    Nor, Carolina
    Gulko, Percio S.
    Xavier, Ricardo Machado
    de Oliveira, Patricia Gnieslaw
    PEPTIDES, 2017, 95 : 57 - 61
  • [27] IL-17A Induced Autophagy That the Proliferation of Rheumatoid Arthritis Fibroblast-like Synoviocytes through Down-Regulation of PI3K/AKT/mTOR Signaling Pathway
    Kim, Sang-Hyon
    Bang, Jihye
    Kim, Ji-Min
    Son, Chang-Nam
    Chae, Jin-Nyeong
    Jeong, Hye-Jin
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [28] Oleanolic Acid Decreases IL-1β-Induced Activation of Fibroblast-Like Synoviocytes via the SIRT3-NF-κB Axis in Osteoarthritis
    Bao, Jiapeng
    Yan, Weifeng
    Xu, Kai
    Chen, Mengyao
    Chen, Zhonggai
    Ran, Jisheng
    Xiong, Yan
    Wu, Lidong
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [29] Halofuginone inhibits TNF-α-induced the migration and proliferation of fibroblast-like synoviocytes from rheumatoid arthritis patients
    Zeng, Shan
    Wang, Kefeng
    Huang, Mingcheng
    Ou, Qian
    Xiao, Youjun
    Shi, Maohua
    Zou, Yaoyao
    Yang, Xiuyan
    Xu, Hanshi
    Liang, Liuqin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 43 : 187 - 194
  • [30] CT2-3 induces cell cycle arrest and apoptosis in rheumatoid arthritis fibroblast-like synoviocytes through regulating PI3K/AKT pathway
    Chen, Jian
    Lin, Xian
    Liu, Kangdi
    He, Juan
    Li, Xin
    Zhang, Chuchu
    Deng, Yongxing
    Luo, Lianxiang
    Tao, Cheng
    Wang, Qingwen
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 956